Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Gain Therapeutics stock

Learn how to easily invest in Gain Therapeutics stock.

Gain Therapeutics Inc is a biotechnology business based in the US. Gain Therapeutics shares (GANX) are listed on the NASDAQ and all prices are listed in US Dollars. Gain Therapeutics employs 25 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Gain Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GANX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Gain Therapeutics stock price (NASDAQ: GANX)

Use our graph to track the performance of GANX stocks over time.

Gain Therapeutics shares at a glance

Information last updated 2022-06-30.
Latest market close$3.47
52-week range$2.33 - $10.41
50-day moving average $3.30
200-day moving average $5.05
Wall St. target price$20.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.23

Buy Gain Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Gain Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Gain Therapeutics price performance over time

Historical closes compared with the close of $3.47 from 2022-07-01

1 week (2022-06-24) -11.48%
1 month (2022-06-03) -0.86%
3 months (2022-04-01) -18.74%
6 months (2022-01-03) -36.21%
1 year (2021-07-02) -65.33%
2 years (2020-06-29) N/A
3 years (2019-06-29) N/A
5 years (2017-06-29) N/A

Gain Therapeutics financials

Revenue TTM $171,466
Gross profit TTM $-6,685,997
Return on assets TTM -21.38%
Return on equity TTM -38.57%
Profit margin 0%
Book value $2.68
Market capitalisation $42.7 million

TTM: trailing 12 months

Gain Therapeutics share dividends

We're not expecting Gain Therapeutics to pay a dividend over the next 12 months.

Gain Therapeutics overview

Gain Therapeutics, Inc. , a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. The company was founded in 2017 and is based in Bethesda, Maryland. .

Frequently asked questions

What percentage of Gain Therapeutics is owned by insiders or institutions?
Currently 24.34% of Gain Therapeutics shares are held by insiders and 9.776% by institutions.
How many people work for Gain Therapeutics?
Latest data suggests 25 work at Gain Therapeutics.
When does the fiscal year end for Gain Therapeutics?
Gain Therapeutics's fiscal year ends in December.
Where is Gain Therapeutics based?
Gain Therapeutics's address is: 4800 Montgomery Lane, Bethesda, MD, United States, 20814
What is Gain Therapeutics's ISIN number?
Gain Therapeutics's international securities identification number is: US36269B1052

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site